The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) is one of four cancer centers involved in testing a new "nanomedicine" ...
Jan 9, 2018
0
299
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...
Nov 21, 2017
0
427
Neurofibromatosis type 1 (NF1)—an autosomal dominant disorder affecting approximately one in every 3,500 people—results in dysfunctional neurofibromin, a protein expressed throughout the body and involved in the RAS signaling ...
Jun 12, 2017
0
9
New research further illuminates the surprising relationship between blood sugar and brain tumors and could begin to shed light on how certain cancers develop.
May 3, 2017
0
1904
A new review proposes a theory to explain how calorie restriction can extend life across a variety of species.
May 3, 2017
0
2
A team of investigators has determined that young children participating in a clinical trial to assess the effectiveness of reduced radiotherapy did worse when there were deviations from the treatment protocol. Results of ...
Apr 6, 2017
0
13
Sending a manned mission to Mars requires more than a powerful launch rocket. Prep work also includes learning how a three-year space flight could affect the human body. With funding from the National Aeronautics and Space ...
Mar 8, 2017
4
777
A research team at the Krembil Research Institute has discovered that a signaling pathway which controls blood vessel development in the brain has the ability to stop brain tumor formation in animal models of medulloblastoma, ...
Nov 8, 2016
0
3
At 38-years-old, Aaron Feldman was in the best shape of his life. He played first base and pitched in two competitive baseball leagues and hit the gym daily. He attributed the pain in his chest to soreness from grueling workouts. ...
Sep 20, 2016
0
1
The world's first face transplant recipient, Frenchwoman Isabelle Dinoire, died of a cancer unrelated to medicine she was taking to stop her body rejecting the graft, doctors said Wednesday.
Sep 7, 2016
0
2
